- Functional interactions of Kv1.3 channels in microglia and T cells and their implications in neurodegenerationby inmunoadminCurr Opin Immunol. 2026 Mar 14;100:102757. doi: 10.1016/j.coi.2026.102757. Online ahead of print. ABSTRACT Kv1.3 is a voltage-gated potassium channel expressed on immune cells. It functions in coordination with calcium channels to maintain cellular homeostasis. Several studies support important roles for Kv1.3 in microglia-driven neuroinflammation and T cell-mediated autoimmunity. Based on recent evidence, Kv1.3 may regulate … Read more
- Malaria immunity in the infant: progress and pitfallsby inmunoadminCurr Opin Immunol. 2026 Mar 13;100:102756. doi: 10.1016/j.coi.2026.102756. Online ahead of print. ABSTRACT We are at the dawn of a new era in the biomedical prevention of childhood malaria. The successful development and ongoing rollout of the first malaria vaccines, RTS,S/AS01E and R21/Matrix-M, have injected much-needed optimism into the malaria prevention field. Additional new vaccines … Read more
- P2 purinergic receptors in systemic lupus erythematosus: from experimental findings to therapeutic perspectivesby inmunoadminCurr Opin Immunol. 2026 Mar 12;100:102752. doi: 10.1016/j.coi.2026.102752. Online ahead of print. ABSTRACT P2 purinergic receptors are activated by extracellular adenosine triphosphate and other nucleotides released during inflammatory processes, cellular stress responses, and amplification by NETosis, thereby serving as pivotal mediators of both innate and adaptive immunity. In patients with active systemic lupus erythematosus (SLE), … Read more
- Current role of ATG in GVHD prevention: optimizing post-transplantation outcomes through combination with PTCYby inmunoadminCurr Opin Immunol. 2026 Mar 10;100:102749. doi: 10.1016/j.coi.2026.102749. Online ahead of print. ABSTRACT Graft versus host disease (GVHD) is one of the major complications of allogeneic hematopoietic cell transplantation (allo-HCT), contributing significantly to post-transplant morbidity and mortality. Anti-thymocyte globulin (ATG) is a widely used GVHD prophylaxis in combination with a calcineurin inhibitor and an antimetabolite. … Read more
- Use of synthetic data, a novel paradigm for immunopathologyby inmunoadminCurr Opin Immunol. 2026 Mar 10;100:102753. doi: 10.1016/j.coi.2026.102753. Online ahead of print. ABSTRACT The complexity and heterogeneity of autoimmune diseases are only partially captured by current analytic tools, even when deep learning techniques are employed to intercept patterns beyond existing dogma. Synthetic data offer a newer paradigm through machine-generated reconstructions of real-world data that faithfully … Read more
- Autoimmunity beyond antibodies: alternative roles of beta-2-glycoprotein I in and out of antiphospholipid syndrome?by inmunoadminCurr Opin Immunol. 2026 Mar 10;100:102748. doi: 10.1016/j.coi.2026.102748. Online ahead of print. ABSTRACT The term autoimmune disease refers to autoantibody-dependent pathophysiological conditions, in which characterising the autoantibodies is essential, as is studying their target(s), the (auto)antigen(s), which represent the other side of the coin. In this review, we aimed to go further inside the ultimate … Read more
- Beyond ion flux: the potassium channel KV1.3 and its regulatory function in neutrophilsby inmunoadminCurr Opin Immunol. 2026 Mar 3;100:102750. doi: 10.1016/j.coi.2026.102750. Online ahead of print. ABSTRACT The voltage-gated potassium channel KV1.3 (KCNA3) is a critical ion channel regulating membrane potential in immune cells, facilitating sustained calcium influx and activating downstream signaling events. Besides its canonical role as an ion channel, KV1.3 has been postulated to exert additional functions … Read more
- Amyloid precursor protein is a subunit of microglial Hv1 channelsby inmunoadminCurr Opin Immunol. 2026 Mar 3;100:102751. doi: 10.1016/j.coi.2026.102751. Online ahead of print. ABSTRACT Voltage-gated proton channels (Hv1) are key regulators of microglial activation, coupling proton extrusion to reactive oxygen species production, cellular pH homeostasis, and pro-inflammatory signaling. Dysregulated Hv1 activity exacerbates neuroinflammation and contributes to a range of central nervous system pathologies. Our recent work … Read more
- Clinical trials and new therapies in Sjögren’s diseaseby inmunoadminCurr Opin Immunol. 2026 Mar 3;100:102743. doi: 10.1016/j.coi.2026.102743. Online ahead of print. ABSTRACT Despite major advances in understanding Sjögren’s disease (SjD), no approved disease-modifying therapies have been approved. Management remains largely symptomatic with the use of off-label immunomodulators for systemic features. This gap highlights the substantial unmet need for targeted treatment. Encouragingly, the therapeutic landscape … Read more
- Targeting synovial fibroblast KCa1.1 channels in rheumatoid arthritisby inmunoadminCurr Opin Immunol. 2026 Mar 3;100:102747. doi: 10.1016/j.coi.2026.102747. Online ahead of print. ABSTRACT Fibroblast-like synoviocytes (FLS) play major roles in the pathogenesis of rheumatoid arthritis (RA). Human and rat FLS express the KCa1.1 channel (BK, Maxi-K, Slo1, and KCNMA1) as their major potassium channel at the plasma membrane. Reducing the expression or function of this … Read more
- Endothelial dysfunction in APS: advancing pathophysiological understanding to improve managementby inmunoadminCurr Opin Immunol. 2026 Mar 2;100:102745. doi: 10.1016/j.coi.2026.102745. Online ahead of print. ABSTRACT Endothelial dysfunction (ED) is a hallmark of antiphospholipid syndrome (APS) driven by chronic antiphospholipid antibody (aPL) exposure. Beyond acute thrombotic events, ED contributes to atherosclerosis, vascular remodelling, stenosis and multi-organ manifestations, positioning the endothelium as a putative target for disease monitoring and … Read more
- Mpox virus immunology: exploring links to autoimmune diseasesby inmunoadminCurr Opin Immunol. 2026 Feb 27;99:102744. doi: 10.1016/j.coi.2026.102744. Online ahead of print. ABSTRACT The reemergence of the mpox virus (MPXV) as a global health threat, with >100 000 cases reported across 115 countries since the WHO’s 2022 alert, has intensified research into its pathophysiology. MPXV exists in two main clades with distinct geographic and clinical … Read more
- Addressing unmet needs in rheumatoid arthritis: the challenge of translating multi-omics into precision therapiesby inmunoadminCurr Opin Immunol. 2026 Feb 27;99:102742. doi: 10.1016/j.coi.2026.102742. Online ahead of print. ABSTRACT Rheumatoid arthritis (RA) is a highly heterogeneous chronic systemic inflammatory disease. Approximately 30-40% of patients exhibit an inadequate response to currently available biologic agents and Janus kinase inhibitors. In recent years, rapid advances in multi-omics technologies, including genomics, temporal transcriptomics, proteomics, metabolomics, … Read more
- Composite and pragmatic measures in psoriatic arthritis: bridging trials and clinical feasibilityby inmunoadminCurr Opin Immunol. 2026 Feb 27;99:102746. doi: 10.1016/j.coi.2026.102746. Online ahead of print. ABSTRACT PURPOSE OF REVIEW: Psoriatic arthritis (PsA) is a multidomain inflammatory disease where no instrument captures the full spectrum of activity or its impact on patients’ lives. Accurate outcome measurement is essential for research and personalized care. This review summarizes advances in PsA … Read more
- Evolution and prospects for the definition of clinically useful endpoints in Sjögren diseaseby inmunoadminCurr Opin Immunol. 2026 Feb 18;99:102741. doi: 10.1016/j.coi.2026.102741. Online ahead of print. ABSTRACT Outcomes in Sjögren disease (SjD) have ranged from diverse symptom scales to the validated EULAR Sjögren’s Syndrome Patient Reported Index (ESSPRI) and EULAR Sjögren’s Syndrome Disease Activity Index (ESSDAI), which now provide a common framework for evaluating symptoms and systemic activity. In … Read more
- Antimicrobial peptides and proteins as rheostats of intestinal homeostasis and immunityby inmunoadminCurr Opin Immunol. 2026 Feb 17;99:102738. doi: 10.1016/j.coi.2026.102738. Online ahead of print. ABSTRACT Antimicrobial peptides and proteins (AMPs) function as molecular rheostats of host-microbe interactions and cell-intrinsic defense. Rather than being binary effectors, they act along a continuum. At basal levels, AMPs maintain harmony with the commensal members of the microbiome, and upon pathogen encounter, … Read more
- T cells in Sjögren’s disease: update on their role in salivary gland pathogenesis and treatmentby inmunoadminCurr Opin Immunol. 2026 Feb 16;99:102739. doi: 10.1016/j.coi.2026.102739. Online ahead of print. ABSTRACT Sjögren’s disease (SjD) is a chronic, systemic autoimmune disease that mainly targets saliva- and tear-producing glands. T-cells are a substantial immune cell subset involved in SjD pathogenesis, including break of tolerance toward self, and constitute a major part of tissue-resident and infiltrating … Read more
- Multiple sclerosis: a disease or a syndrome?by inmunoadminCurr Opin Immunol. 2026 Feb 14;99:102736. doi: 10.1016/j.coi.2026.102736. Online ahead of print. ABSTRACT Multiple sclerosis (MS) is traditionally considered a chronic immune-mediated disease of the central nervous system. However, increasing evidence suggests substantial clinical, radiological, and immunopathological heterogeneity among individuals diagnosed with MS. In recent years, increasing awareness of this heterogeneity has led to a … Read more
- TRPM7 channel-kinase in immunity: new frontiers of an emerging therapeutic targetby inmunoadminCurr Opin Immunol. 2026 Feb 13;99:102734. doi: 10.1016/j.coi.2026.102734. Online ahead of print. ABSTRACT The cation channel and protein kinase transient receptor potential cation channel subfamily M member 7 (TRPM7) has been linked to immune homeostasis, immune cell signaling and differentiation, and inflammatory diseases. Its importance in guiding ion-mediated cellular responses, funneling discrete kinase signal transduction … Read more
- Minor salivary gland biopsy in Sjogren’s disease: a diagnostic and prognostic tool toward precision medicineby inmunoadminCurr Opin Immunol. 2026 Feb 13;99:102737. doi: 10.1016/j.coi.2026.102737. Online ahead of print. ABSTRACT Minor salivary gland biopsy occupies a distinctive position in the evaluation of Sjögren disease (SjD), offering diagnostic and prognostic insights that are rarely achievable in other systemic autoimmune conditions. It contributes essential diagnostic information, particularly for patients lacking anti-Ro/SSA antibodies or pediatric … Read more
- Cell death pathways in graft-versus-host diseaseby inmunoadminCurr Opin Immunol. 2026 Feb 13;99:102740. doi: 10.1016/j.coi.2026.102740. Online ahead of print. ABSTRACT Regulated cell death, including apoptosis, necroptosis, and pyroptosis, as well as cell death arising from disrupted cellular homeostasis, such as ferroptosis and dysregulated autophagy, is implicated in cancer, autoimmunity, and transplantation biology. Graft-versus-host disease (GVHD), a major cause of morbidity and mortality … Read more
- Rheumatoid arthritis: revisiting pathogenesis for prevention, stratification, and repairby inmunoadminCurr Opin Immunol. 2026 Feb 11;99:102735. doi: 10.1016/j.coi.2026.102735. Online ahead of print. ABSTRACT The clinical heterogeneity of rheumatoid arthritis (RA) reflects a series of dynamic immunological imbalances rather than a single dominant mechanism. In this review, we propose that RA progression is best understood as a sequence of three functional balances. The first contrasts pathogenic … Read more
- Malaria in pregnancy at the frontline: a delicate balanceby inmunoadminCurr Opin Immunol. 2026 Jan 27;99:102726. doi: 10.1016/j.coi.2026.102726. Online ahead of print. ABSTRACT Malaria during pregnancy continues to compromise maternal, fetal, and subsequently infant health. This burden has increased in Africa, though it has decreased elsewhere. Here, we provide a concise review of recent findings on malaria in pregnancy, addressing pathogenesis, immunity, offspring outcomes, and … Read more
- Patterns and trends in sarcoidosis: an epidemiological perspectiveby inmunoadminCurr Opin Immunol. 2026 Jan 23;99:102723. doi: 10.1016/j.coi.2025.102723. Online ahead of print. ABSTRACT The incidence, prevalence, and burden of sarcoidosis is increasing worldwide. The Nordic countries have the highest incidence with lowest rates reported in Asia. In the United States, Black females have the highest incidence and prevalence of disease. The phenotypic manifestations of sarcoidosis … Read more
- Evaluating the pandemic potential of Zika virus in a changing global landscapeby inmunoadminCurr Opin Immunol. 2026 Jan 22;99:102724. doi: 10.1016/j.coi.2026.102724. Online ahead of print. ABSTRACT As of 2024, the World Health Organization declared the Zika virus (ZIKV), an emerging flavivirus, as a high-priority pathogen with the potential to cause future Public Health Emergencies of International Concern. Although the last major outbreak of ZIKV occurred in 2015-2016, ongoing … Read more
- A comprehensive study on the effect of alglucosidase alpha and immunomodulation on survival, motor and cardiac outcome, creatine kinase and antibody titers in classic infantile Pompe disease: the Monza experienceby inmunoadminCurr Opin Immunol. 2026 Jan 22;99:102725. doi: 10.1016/j.coi.2026.102725. Online ahead of print. ABSTRACT We report on 13 classic infantile Pompe patients, including four cross-reactive immunological material negative (31%), treated with alglucosidase alpha (rhGAA) at Fondazione IRCCS San Gerardo, Monza, between 2003 and 2024. Median age at rhGAA initiation was 3.3 months, with nine patients (69%) … Read more
- Optimizing patient-reported outcomes for sarcoidosisby inmunoadminCurr Opin Immunol. 2026 Jan 14;99:102720. doi: 10.1016/j.coi.2025.102720. Online ahead of print. ABSTRACT Patients with sarcoidosis can present with a wide range of symptoms that impact their quality of life (QoL). QoL represents one of the most important treatment priorities for patients. Therefore, measuring what matters to patients is of great importance, though it can … Read more
- Elderly-onset rheumatoid arthritis as a distinct entity: mechanisms, manifestations, and treatmentby inmunoadminCurr Opin Immunol. 2026 Jan 13;99:102721. doi: 10.1016/j.coi.2025.102721. Online ahead of print. ABSTRACT Elderly-onset rheumatoid arthritis (EORA), defined as onset at ≥60 years, is a clinically distinct and increasingly prevalent subset of rheumatoid arthritis (RA). This review synthesizes evidence that EORA is not merely late-onset RA but a pathogenically unique entity, driven by immune aging, … Read more
- A critical look at animal and cellular models in autoinflammatory diseasesby inmunoadminCurr Opin Immunol. 2026 Jan 13;99:102719. doi: 10.1016/j.coi.2025.102719. Online ahead of print. ABSTRACT Autoinflammatory diseases (AIDs) comprise a diverse group of conditions arising from dysregulated immune control due to congenital or acquired genetic abnormalities in innate immune pathways, and patients typically require lifelong treatment. Owing to their rarity, access to patient samples is limited, making … Read more
- New autoantibodies in Sjögren’s diseaseby inmunoadminCurr Opin Immunol. 2026 Jan 13;99:102722. doi: 10.1016/j.coi.2025.102722. Online ahead of print. ABSTRACT Primary Sjögren’s disease (SjD) is a systemic autoimmune disorder where diagnosis relies on the presence of Ro/SS-A and La/SS-B autoantibodies. However, approximately one-third of SjD patients are seronegative, often requiring an invasive minor salivary gland biopsy, which can lead to significant diagnostic … Read more
- A throwback on 25 years in pannexin researchby inmunoadminCurr Opin Immunol. 2026 Jan 9;99:102718. doi: 10.1016/j.coi.2025.102718. Online ahead of print. ABSTRACT Cellular channels consisting of pannexins facilitate signaling between the intracellular and extracellular environment. In this respect, pannexin channel opening serves as a pivotal trigger for both inflammatory processes and cell death. While pannexin channels also contribute to normal physiological functions, their roles … Read more
- The role of stromal cell immunobiology in understanding and managing Sjögren’s diseaseby inmunoadminCurr Opin Immunol. 2026 Jan 9;99:102714. doi: 10.1016/j.coi.2025.102714. Online ahead of print. ABSTRACT Sjögren’s disease (SjD) is a systemic, heterogeneous autoimmune disorder, clinically dominated by dryness symptoms resulting from inflammatory infiltration of exocrine glands. To date, no validated and resolutive therapeutic strategies are available. Stromal cells are increasingly recognized as critical players in SjD pathogenesis. … Read more
- Metabolomic signaling in sarcoidosis pathogenesisby inmunoadminCurr Opin Immunol. 2026 Jan 9;99:102715. doi: 10.1016/j.coi.2025.102715. Online ahead of print. ABSTRACT Sarcoidosis is a multisystem inflammatory disorder characterized by noncaseating granulomas in various organs, predominantly affecting the lungs and lymphatic system. Although the etiology of sarcoidosis remains unknown, it is believed to result from an abnormal immune response triggered by environmental agents in … Read more
- Markers predicting lymphoma development in Sjögren disease: current status and future perspectivesby inmunoadminCurr Opin Immunol. 2026 Jan 8;99:102717. doi: 10.1016/j.coi.2025.102717. Online ahead of print. ABSTRACT We aim to present recent advancements in predictive markers for lymphomagenesis in SjD, concisely organize existing knowledge, and identify corresponding unmet needs and future perspectives. First, we briefly describe the mechanisms of lymphomagenesis in SjD. Followingly, the reasons justifying the importance of … Read more
- Emerging diagnostic techniques in sarcoidosis: a path forwardby inmunoadminCurr Opin Immunol. 2026 Jan 8;99:102716. doi: 10.1016/j.coi.2025.102716. Online ahead of print. ABSTRACT Sarcoidosis is a complex and heterogenous disease of which the diagnosis is based on clinical and radiological findings, histopathology showing non-caseating granulomas, and exclusion of other granulomatous diseases. Several tools are well established in the diagnostic pathway, such as pulmonary function tests, … Read more
- Mapping the B-cell axis in Sjögren’s disease: repertoire, microenvironment, and potential routes to precision treatmentby inmunoadminCurr Opin Immunol. 2025 Dec 22;98:102712. doi: 10.1016/j.coi.2025.102712. Online ahead of print. ABSTRACT Sjögren’s disease (SjD) is a chronic autoimmune disorder in which sustained B-cell activation drives glandular injury and systemic complications. Epithelial stress and interferon tone amplify B-cell activating factor (BAFF)-dependent survival, skewing selection toward autoreactive clones in both glands and blood. In addition, … Read more
- Diet-derived microbial metabolites as regulators of immune functionby inmunoadminCurr Opin Immunol. 2025 Dec 22;98:102713. doi: 10.1016/j.coi.2025.102713. Online ahead of print. ABSTRACT The intestinal microbiota transforms dietary components into bioactive metabolites that profoundly influence mucosal and systemic immunity. Short-chain fatty acids, secondary bile acids and tryptophan-derived indoles are among the most studied microbial metabolites shaping T, B and innate immune cell functions through a … Read more
- Complement deficiencies and infectionsby inmunoadminCurr Opin Immunol. 2025 Dec 19;98:102711. doi: 10.1016/j.coi.2025.102711. Online ahead of print. ABSTRACT The complement system is a central component of innate immunity, mediating opsonization, chemotaxis, cytolysis, and shaping adaptive responses. Deficiencies in complement proteins, whether inherited or acquired, predispose to severe infections, particularly with encapsulated bacteria such as Neisseria meningitidis and Streptococcus pneumoniae. Although … Read more
- From X-rays to advanced imaging modalities in pulmonary sarcoidosisby inmunoadminCurr Opin Immunol. 2025 Dec 16;98:102709. doi: 10.1016/j.coi.2025.102709. Online ahead of print. ABSTRACT Sarcoidosis is a multisystem inflammatory disorder characterized by noncaseating epithelioid granulomata, most commonly involving the lungs and thoracic lymph nodes. Although definitive diagnosis relies on tissue biopsy, characteristic findings detected on computed tomography (CT) often allow a confident diagnosis. Atypical imaging patterns, … Read more
- The role of linked recognition and B cell precursor frequency in alloimmunization to transfused RBCsby inmunoadminCurr Opin Immunol. 2025 Dec 16;98:102705. doi: 10.1016/j.coi.2025.102705. Online ahead of print. ABSTRACT Despite multiple alloantigenic differences in every allotransfusion, only 3-6% of transfusion recipients develop a detectable alloantibody even with multiple transfusions. Moreover, patients typically become alloimmunized only to some of the alloantigens to which they are exposed. In recent decades, precursor frequency of … Read more
- Indole sensing in host, microbiota, and pathogen interactionsby inmunoadminCurr Opin Immunol. 2025 Dec 16;98:102710. doi: 10.1016/j.coi.2025.102710. Online ahead of print. ABSTRACT Indole is an abundant metabolite in the mammalian gut. Both mammals and microorganisms sense it. Indole is a signal used to communicate and gauge the gut environment. Indole is produced by bacteria that encode the tryptophanase enzyme. However, indole sensing is not … Read more
- The indole-brain connection: neuroimmune mechanisms and therapyby inmunoadminCurr Opin Immunol. 2025 Dec 11;98:102708. doi: 10.1016/j.coi.2025.102708. Online ahead of print. ABSTRACT The microbiota-gut-brain axis (MGBA) has been recognized as an important communication network between the gut and the brain. This network operates through immune, neural, and endocrine pathways, wherein microbiota-derived metabolites act as essential messengers regulating MGBA. Among gut metabolites, indole and its … Read more
- Salivary gland organoids and the future of modeling autoimmune epithelitis in Sjögren’s diseaseby inmunoadminCurr Opin Immunol. 2025 Dec 11;98:102707. doi: 10.1016/j.coi.2025.102707. Online ahead of print. ABSTRACT Sjögren’s disease (SjD) is a systemic autoimmune disorder characterized by a striking tropism for epithelial tissues, particularly the salivary and lacrimal glands. Lack of function of the salivary glands (SGs) leads to a panoply of symptoms, dramatically reducing patient quality of life. … Read more
- Revisiting tryptophan metabolism in cancer: complexity, context, and spatial heterogeneityby inmunoadminCurr Opin Immunol. 2025 Dec 9;98:102706. doi: 10.1016/j.coi.2025.102706. Online ahead of print. ABSTRACT Tryptophan (TRP) metabolism has long been associated with cancer immunity, primarily through the kynurenine pathway mediated by indoleamine-2,3-dioxygenase 1 (IDO1) and tryptophan-2,3-dioxygenase (TDO2). Both enzymes can deplete TRP within cells and in local microenvironments, triggering dysfunction of T cells with anti-tumor functions. … Read more
- Sarcoidosis of the nervous system: a rare but serious manifestationby inmunoadminCurr Opin Immunol. 2025 Dec 8;98:102704. doi: 10.1016/j.coi.2025.102704. Online ahead of print. ABSTRACT Clinically overt granulomatous involvement of the nervous system, or neurosarcoidosis, occurs in up to 5% of patients with sarcoidosis. Diagnosing neurosarcoidosis is often challenging due to its highly heterogeneous and frequently nonspecific clinical presentations, as well as the difficulty in obtaining tissue … Read more
- Interferons in Sjogren’s disease: current status and future prospectsby inmunoadminCurr Opin Immunol. 2025 Dec 4;98:102703. doi: 10.1016/j.coi.2025.102703. Online ahead of print. ABSTRACT Sjögren’s disease (SjD) is a systemic autoimmune disorder marked by chronic immune activation, with a central role attributed to the interferon (IFN) system. The so-called ‘IFN signature’ at both tissue and peripheral levels has long been recognized as a hallmark of SjD, … Read more
- Is psoriatic arthritis a dissemination of cutaneous psoriatic TRM cells? Role of tissue-resident memory T cells (TRM) in psoriatic diseaseby inmunoadminCurr Opin Immunol. 2025 Dec 2;98:102702. doi: 10.1016/j.coi.2025.102702. Online ahead of print. ABSTRACT Tissue resident memory T cells (TRM) cells are a recently defined subtype of nonrecirculating memory T cells with longevity and protective functions in peripheral tissues. The discovery of T cells resident in diverse tissues has altered our understanding of adaptive immunity with … Read more
- Primary angiitis of the central nervous systemby inmunoadminCurr Opin Immunol. 2025 Nov 20;98:102691. doi: 10.1016/j.coi.2025.102691. Online ahead of print. ABSTRACT Primary central nervous system vasculitis, also known as primary angiitis of CNS (PACNS), is a rare and heterogeneous inflammatory disorder of blood vessels restricted to the central nervous system. The most common presenting symptoms are headache, focal neurological deficits, and altered cognition. … Read more
- Toward indole postbiotics precision therapy via AI-powered drug delivery technologiesby inmunoadminCurr Opin Immunol. 2025 Nov 11;98:102692. doi: 10.1016/j.coi.2025.102692. Online ahead of print. ABSTRACT Recent advancements in microbiome research have revealed the restorative capacities of postbiotics, including indole and its derivatives generated via bacterial tryptophan metabolism. Widespread in prokaryotic and eukaryotic communities, indole and its derivatives are uniquely suited to promote host physiology and homeostasis at … Read more
- The power of genetics in decoding Sjögren’s disease: current status and future developmentby inmunoadminCurr Opin Immunol. 2025 Nov 10;98:102690. doi: 10.1016/j.coi.2025.102690. Online ahead of print. ABSTRACT Sjögren’s disease (SjD) is the second most common systemic autoimmune disease in the United States. SjD patients are predominantly women 30-50 years of age and exhibit heterogeneous clinical manifestations, including symptoms of extensive dryness, chronic fatigue, and joint pain, and various major … Read more
- Can we cure autoimmunity?by inmunoadminCurr Opin Immunol. 2025 Nov 10;98:102684. doi: 10.1016/j.coi.2025.102684. Online ahead of print. ABSTRACT Autoimmune diseases have, until recently, been treated with relatively broad immunosuppressive regimens. Newer, more focused monoclonal antibody therapies directed to specific targets, for example, anti-TNF or anti-B cell therapies, can produce significant immunosuppression. ‘Remission’ of autoimmune disease that requires ongoing immunosuppression is … Read more
- Pulmonary transfusion reactions as an immunological spectrum disorderby inmunoadminCurr Opin Immunol. 2025 Nov 6;98:102689. doi: 10.1016/j.coi.2025.102689. Online ahead of print. ABSTRACT Transfusion-associated circulatory overload (TACO) and transfusion-related acute lung injury (TRALI) are leading causes of transfusion-related morbidity and mortality. Despite distinct diagnostic criteria, both syndromes present similarly with respiratory distress and pulmonary edema. In recent research, they increasingly appear to share pathophysiological and … Read more
- Role of ion channels in immune regulation of psoriasisby inmunoadminCurr Opin Immunol. 2025 Nov 5;98:102688. doi: 10.1016/j.coi.2025.102688. Online ahead of print. ABSTRACT Psoriasis is a chronic inflammatory skin disease marked by abnormal keratinocyte growth, immune dysfunction, and a weakened skin barrier. Affecting 2-3% of the global population, it lowers quality of life and is linked to systemic conditions. Though treatments have improved, many patients … Read more
- Indole-3-acetic acid from plants and microbes in human healthby inmunoadminCurr Opin Immunol. 2025 Oct 31;98:102683. doi: 10.1016/j.coi.2025.102683. Online ahead of print. ABSTRACT The production of indole-3-acetic acid (IAA, auxin) is universal in microbes and plants, and contributes to human wellness, acting as an anticancer and anti-inflammatory agent. This review highlights the ubiquity of IAA production by microbes and plants, as well as its role … Read more
- Regulatory T cell approaches for graft-versus-host disease preventionby inmunoadminCurr Opin Immunol. 2025 Oct 30;98:102685. doi: 10.1016/j.coi.2025.102685. Online ahead of print. ABSTRACT Regulatory T cells (Tregs) are a rare subset of T cells that are potent regulators of the immune system. As a result, the use of Tregs to prevent undesired immune activation and to re-establish immune balance is an attractive cellular therapy approach. … Read more
- Complement-targeting therapies in hemolytic diseasesby inmunoadminCurr Opin Immunol. 2025 Oct 29;98:102686. doi: 10.1016/j.coi.2025.102686. Online ahead of print. ABSTRACT Complement inhibition has revolutionized the management of hemolytic diseases by targeting the underlying drivers of red blood cell destruction in disorders such as paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, and cold agglutinin disease. Recent advances have expanded the therapeutic landscape beyond … Read more
- Local complement inhibition by selective precision-targeted therapiesby inmunoadminCurr Opin Immunol. 2025 Oct 29;98:102687. doi: 10.1016/j.coi.2025.102687. Online ahead of print. ABSTRACT Excessive complement activation represents a major pathogenic mechanism for a range of serious human diseases. Complement-inhibitory therapeutics have been approved for a number of rare and ultra-rare conditions, with several others in clinical development. The vast majority of these complement-targeted drugs act … Read more
- Autoimmunity, epitope analysis, and molecular mimicryby inmunoadminCurr Opin Immunol. 2025 Oct 27;97:102681. doi: 10.1016/j.coi.2025.102681. Online ahead of print. ABSTRACT Infectious agents are potential triggers for autoimmune diseases (ADs) in susceptible individuals, with infection being a key factor in initiating autoimmunity. Epidemiological and experimental evidence suggests molecular mimicry as a plausible mechanism for breaking peripheral tolerance, leading to clinical disease. However, molecular … Read more
- T follicular helper cell development during malariaby inmunoadminCurr Opin Immunol. 2025 Oct 23;97:102682. doi: 10.1016/j.coi.2025.102682. Online ahead of print. ABSTRACT Malaria is a life-threatening disease affecting more than 200 million people worldwide. CD4 T helper 1 (Th1) and T follicular helper (Tfh) cells are critical for stimulating phagocyte activation and humoral immunity, yet sterilizing, protective immune memory responses rarely develop. Malaria induces … Read more
- Mechanobiology of neutrophil inflammasome signaling in psoriasisby inmunoadminCurr Opin Immunol. 2025 Oct 17;97:102680. doi: 10.1016/j.coi.2025.102680. Online ahead of print. ABSTRACT While T cells play a prominent role, polymorphonuclear neutrophils (PMN) are also significant players in the pathogenesis of psoriasis. This review details the mechanobiology of PMN in the amplification of skin inflammation, a process often under-scrutinized compared to T cell pathways. PMN … Read more
- Antiviral responses in peripheral and brain neuronsby inmunoadminCurr Opin Immunol. 2025 Oct 14;97:102678. doi: 10.1016/j.coi.2025.102678. Online ahead of print. ABSTRACT Neurotropic viruses represent a public health challenge due to their ability to cause severe neurological conditions, including meningitis, encephalitis, and paralysis. Although many studies have investigated the immune responses to viral infections in the brain and other nervous system targets, most have … Read more
- Treating sarcoidosis: when less is moreby inmunoadminCurr Opin Immunol. 2025 Oct 13;97:102679. doi: 10.1016/j.coi.2025.102679. Online ahead of print. ABSTRACT Sarcoidosis is a heterogeneous condition, with some presentations associated with spontaneous remission and favourable outcome without treatment. Other presentations, including small fibre neuropathy, arthropathy and sarcoid-associated fatigue, can cause disabling symptoms that may not respond to disease-modifying therapies and must be managed … Read more
- Deciphering and harnessing gut microbiota-associated immune regulation in acute graft-versus-host diseaseby inmunoadminCurr Opin Immunol. 2025 Oct 10;97:102676. doi: 10.1016/j.coi.2025.102676. Online ahead of print. ABSTRACT Allogeneic hematopoietic stem cell transplantation represents a curative treatment of choice for numerous severe hematological malignancies. While donor-derived transplanted T cells can limit disease relapse (GvT/GvL effect), they also induce, in 30-50% of the patients, acute graft-versus-host disease (aGvHD), a severe condition … Read more
- Optimizing post-transplantation cell therapies to enhance graft-versus-leukemia effects in hematological malignanciesby inmunoadminCurr Opin Immunol. 2025 Oct 10;97:102675. doi: 10.1016/j.coi.2025.102675. Online ahead of print. ABSTRACT Allogeneic hematopoietic cell transplantation (HCT) can cure patients with high-risk hematologic malignancies. Donor T and natural killer (NK) cells contribute to graft-versus-leukemia (GVL) effects that provide relapse protection. Post-HCT relapses often represent inadequate GVL, but alloreactive lymphocytes that confer GVL may also … Read more
- The epidermal immune microenvironment plays a central role in the pathogenesis of psoriasisby inmunoadminCurr Opin Immunol. 2025 Oct 9;97:102674. doi: 10.1016/j.coi.2025.102674. Online ahead of print. ABSTRACT Psoriasis is a chronic immune-mediated skin disease whose inflammation can affect other systems and lead to various comorbidities. As a model inflammatory skin disease, while advances in mechanistic insights and targeted therapies have improved outcomes, unmet clinical needs persist. Modern technologies like … Read more
- Layers of defense: protection from respiratory viruses by epithelial-intrinsic immunityby inmunoadminCurr Opin Immunol. 2025 Oct 9;97:102677. doi: 10.1016/j.coi.2025.102677. Online ahead of print. ABSTRACT A central challenge in defending mucosal barriers is protecting against pathogens while also limiting excessive inflammation. Respiratory viruses are a prime example – respiratory viruses present a threat to their target cells, the epithelial cells that line the airways, but excessive leukocyte … Read more
- When granulomatous inflammation becomes visible: insights into cutaneous sarcoidosisby inmunoadminCurr Opin Immunol. 2025 Oct 4;97:102673. doi: 10.1016/j.coi.2025.102673. Online ahead of print. ABSTRACT Cutaneous involvement of sarcoidosis can provide important insights into the presence and prognosis of systemic involvement. Recent insights into the underlying pathophysiology of sarcoidosis have allowed for more targeted therapy, including inhibition of the JAK-STAT and mTOR pathways. In this review article, … Read more
- COVID-19 and inflammatory bowel disease – what to knowby inmunoadminCurr Opin Immunol. 2025 Sep 30;97:102661. doi: 10.1016/j.coi.2025.102661. Online ahead of print. ABSTRACT Inflammatory bowel disease (IBD) represents a chronic inflammation of the gastrointestinal tract that arises from a complex interplay between a dysregulated immune response in genetically predisposed individuals. IBD can further be classified into its two main subtypes, Crohn’s disease and ulcerative colitis. … Read more
- The outcome of severe MIS-C managed at the Italian epicenter of the SARS-CoV-2 epidemic: a follow-up study of 50 consecutive patientsby inmunoadminCurr Opin Immunol. 2025 Sep 22;97:102659. doi: 10.1016/j.coi.2025.102659. Online ahead of print. ABSTRACT BACKGROUND: During the SARS-CoV-2 pandemic, we described a peak of a Kawasaki-like disease in children, later renamed multisystem inflammatory syndrome in children (MIS-C). We report the long-term outcomes of MIS-C patients who presented to our center. METHODS: We recorded clinical features and … Read more
- From genes to granulomas: the genetic blueprint of sarcoidosisby inmunoadminCurr Opin Immunol. 2025 Sep 19;97:102663. doi: 10.1016/j.coi.2025.102663. Online ahead of print. ABSTRACT Sarcoidosis is a complex, polygenic, and multifactorial disease characterized by granulomas in affected organs, which are the hallmark of the condition. Genetic susceptibility, environmental influences, and lifestyle factors play key roles in its development. Although the exact molecular mechanisms are not yet … Read more
- Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis: current status and optimization strategiesby inmunoadminCurr Opin Immunol. 2025 Sep 19;97:102662. doi: 10.1016/j.coi.2025.102662. Online ahead of print. ABSTRACT Since its first application in HLA-haploidentical settings, post-transplant cyclophosphamide (PTCy) has become a standard for graft-versus-host disease (GVHD) prophylaxis, with its use expanding to matched and mismatched hematopoietic cell transplantation. Its major clinical advantages include versatility and cost-effectiveness, providing robust GVHD prevention … Read more
- Microglia and myeloperoxidase in neuroinflammatory and neurodegenerative diseasesby inmunoadminCurr Opin Immunol. 2025 Sep 17;97:102660. doi: 10.1016/j.coi.2025.102660. Online ahead of print. ABSTRACT The dogma of an impenetrable blood-brain barrier (BBB) has given way to the view that resident immune cells within the central nervous system respond to a variety of blood-borne soluble factors, particularly cytokines, and play an important functional role. In particular, microglia … Read more
- Advances in treatment of psoriatic arthritis: current guidelines and emerging therapiesby inmunoadminCurr Opin Immunol. 2025 Sep 15;97:102658. doi: 10.1016/j.coi.2025.102658. Online ahead of print. ABSTRACT Psoriatic arthritis (PsA) is a multifaceted autoimmune condition that affects the peripheral and axial joints, entheses, skin, and nails. The management of PsA relies on prompt diagnosis and early initiation of effective treatment to minimize joint destruction. Treatment options for PsA are … Read more
- Protective or pathogenic? Tuft cells shape divergent immune outcomes in helminth and viral infectionsby inmunoadminCurr Opin Immunol. 2025 Sep 12;97:102657. doi: 10.1016/j.coi.2025.102657. Online ahead of print. ABSTRACT Tuft cells are epithelial sentinels that monitor the luminal environment at barrier sites throughout the body. Their function as crucial initiators of type 2 immunity against helminths and protists in the intestine emerged nearly a decade ago. Since then, key tuft cell … Read more
- Skin manifestations of SARS-CoV-2 infection and its vaccinationby inmunoadminCurr Opin Immunol. 2025 Sep 11;97:102656. doi: 10.1016/j.coi.2025.102656. Online ahead of print. ABSTRACT SARS-CoV-2 infection and vaccination are associated with a broad range of skin manifestations, including chilblains, urticaria, morbilliform and papulovesicular rashes, purpuric-necrotic lesions, and autoimmune flares. These patterns reflect differences in the timing and nature of type I interferon (IFN-I) responses. Rapid TLR7-mediated … Read more
- Approved and emerging therapies for glucocorticoid-refractory chronic graft-versus-host diseaseby inmunoadminCurr Opin Immunol. 2025 Sep 9;97:102654. doi: 10.1016/j.coi.2025.102654. Online ahead of print. ABSTRACT Glucocorticoid-refractory chronic graft-versus-host disease (glucocorticoid-refractory cGVHD) remains a major barrier to long-term survival and quality of life following allogeneic hematopoietic stem cell transplantation (allo-HSCT), affecting 30-70% to half of patients with chronic GVHD who fail corticosteroid therapy. In recent years, the Food … Read more
- Complement in systemic lupus erythematosus across time and space: from tolerance to tissue injury and from extracellular to intracellular functionsby inmunoadminCurr Opin Immunol. 2025 Sep 5;97:102655. doi: 10.1016/j.coi.2025.102655. Online ahead of print. ABSTRACT The complement system plays a paradoxical role in systemic lupus erythematosus physiopathology, acting both as a protective mechanism and as a driver of tissue injury, depending on disease stage. Neutrophil extracellular traps (NETs) further exacerbate disease activity by promoting complement activation and … Read more
- C1 inhibitor: from complement system to bradykinin angioedemaby inmunoadminCurr Opin Immunol. 2025 Sep 3;97:102653. doi: 10.1016/j.coi.2025.102653. Online ahead of print. ABSTRACT C1 Inhibitor (C1INH) is a crucial regulator of multiple plasmatic pathways, including complement, coagulation, kallikrein-kinin systems, and fibrinolysis. C1INH deficiency results in the downstream overproduction of the vasoactive peptide bradykinin (BK), the primary mediator of angioedema (AE), a rare disease characterized by … Read more
- Human inborn errors of type I interferon-independent intrinsic immunity in nonleukocytic cellsby inmunoadminCurr Opin Immunol. 2025 Sep 2;97:102651. doi: 10.1016/j.coi.2025.102651. Online ahead of print. ABSTRACT ‘Intrinsic immunity’ is often used to refer to mechanisms of host defense operating in nonleukocytic cells. This term can refer to the intrinsic capacity of an individual cell to fend off invading microbes without help from other cells or of a group … Read more
- Challenges in diagnosis of sarcoidosisby inmunoadminCurr Opin Immunol. 2025 Sep 1;97:102652. doi: 10.1016/j.coi.2025.102652. Online ahead of print. ABSTRACT PURPOSE OF REVIEW: Diagnosing sarcoidosis remains challenging. Histology findings and a variable clinical presentation can mimic other infectious, malignant, and autoimmune diseases. This review synthesizes current evidence on histopathology, sampling techniques, imaging modalities, and biomarkers and explores how emerging ‘omics’ and artificial … Read more
- Roles of endothelial cells during infectionby inmunoadminCurr Opin Immunol. 2025 Aug 29;97:102648. doi: 10.1016/j.coi.2025.102648. Online ahead of print. ABSTRACT Endothelial cells (ECs) integrate immune and vascular functions to promote host defense against pathogens. While previously studied as forming passive flow conduits, ECs are now recognized as active contributors to maladaptive inflammation. During acute infection, ECs may promote tissue pathologies, including hypoxia, … Read more
- Transfusion-related acute lung injury: experimental models to study pathogenesis and therapeutic strategiesby inmunoadminCurr Opin Immunol. 2025 Aug 26;96:102650. doi: 10.1016/j.coi.2025.102650. Online ahead of print. ABSTRACT Transfusion-related acute lung injury (TRALI) is a life-threatening complication of blood transfusion, with mortality rates exceeding 40% in critically ill patients. Despite its clinical severity, TRALI pathogenesis remains unclear, leaving clinicians struggling to fully understand and manage it due to its unpredictable … Read more
- Emerging novel therapies for steroid-refractory acute graft-versus-host disease: recent advances and future directionsby inmunoadminCurr Opin Immunol. 2025 Aug 26;96:102649. doi: 10.1016/j.coi.2025.102649. Online ahead of print. ABSTRACT Acute graft-versus-host disease (aGVHD) is a significant complication of allogeneic hematopoietic cell transplantation (allo-HCT), characterized by immune-mediated tissue damage from donor immune cells. Standard treatment of aGVHD involves systemic corticosteroids, but many patients do not respond adequately, with 30%-50% of patients being … Read more
- B-cell antigen presentation in central nervous system autoimmunityby inmunoadminCurr Opin Immunol. 2025 Aug 25;96:102647. doi: 10.1016/j.coi.2025.102647. Online ahead of print. ABSTRACT The role of B cells in central nervous system (CNS) autoimmunity was initially highlighted by successful clinical trials of anti-CD20 monoclonal antibodies in multiple sclerosis (MS). Research in MS as well as in aquaporin 4 (AQP4)-IgG+ neuromyelitis optica (NMO) and myelin oligodendrocyte … Read more
- From metabolomics to transfusion-associated immunomodulationby inmunoadminCurr Opin Immunol. 2025 Aug 21;96:102646. doi: 10.1016/j.coi.2025.102646. Online ahead of print. ABSTRACT PURPOSE OF REVIEW: This review summarizes recent advances in metabolomics that have enhanced our understanding of transfusion-related immunomodulation (TRIM), highlighting how biochemical changes in stored blood products – with a focus on packed red blood cells – affect recipient immune responses. RECENT … Read more
- Microbial regulation of serotonin and neuroimmune interactionsby inmunoadminCurr Opin Immunol. 2025 Aug 20;96:102639. doi: 10.1016/j.coi.2025.102639. Online ahead of print. ABSTRACT Bidirectional communication between the gut microbiota and neuroimmune system is essential during host-microbiome interactions. Recent research has begun to unravel microbiome-neuroimmune crosstalk and suggest classical neurochemicals as key molecular players. Serotonin, a tryptophan-derived neurochemical found across the kingdom of life, is increasingly … Read more
- Recent progress in understanding of allergic transfusion reactionby inmunoadminCurr Opin Immunol. 2025 Aug 20;96:102644. doi: 10.1016/j.coi.2025.102644. Online ahead of print. ABSTRACT Allergic transfusion reactions (ATRs) are among the most common adverse nonhemolytic transfusion reactions. However, since ATR is diagnosed based only on clinical observations, contrary to other allergic diseases, the causal relationship between a given ATR and the corresponding transfusion remains ambiguous in … Read more
- Potential immune consequences of cold-stored platelet transfusionby inmunoadminCurr Opin Immunol. 2025 Aug 19;96:102645. doi: 10.1016/j.coi.2025.102645. Online ahead of print. ABSTRACT The rising interest in using cold-stored platelets (CSP) for improving outcomes in patients with active bleeding has led to multiple clinical trials with the goal of determining the in vivo hemostatic efficacy of CSP compared to standard-of-care room temperature-stored platelets. These trials … Read more
- Checkpoint agonists – immunoregulatory role and its implications in the treatment of psoriasis and psoriatic arthritisby inmunoadminCurr Opin Immunol. 2025 Aug 18;96:102641. doi: 10.1016/j.coi.2025.102641. Online ahead of print. ABSTRACT Psoriasis and psoriatic arthritis are chronic autoimmune diseases characterized by dysregulated immune responses, particularly involving Th17 cells. Immune checkpoint molecules such as programmed death-1 (PD-1) and its ligands (PD-L1/PD-L2) are critical for maintaining immune tolerance. Disruptions in these pathways contribute to psoriatic … Read more
- SARS-CoV-2 and chronic kidney disease: challenges and future directionsby inmunoadminCurr Opin Immunol. 2025 Aug 18;96:102642. doi: 10.1016/j.coi.2025.102642. Online ahead of print. ABSTRACT Patients with chronic kidney disease (CKD), especially those with end-stage kidney disease on dialysis or kidney transplant recipients (KTRs), are highly susceptible to infections, including the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The COVID-19 pandemic disproportionately affected this vulnerable population, … Read more
- Can we cure lupus?by inmunoadminCurr Opin Immunol. 2025 Aug 14;96:102640. doi: 10.1016/j.coi.2025.102640. Online ahead of print. ABSTRACT A general understanding of the mechanisms leading to the development of systemic lupus has emerged over recent years, yet treatment of the illness remains largely empiric and unsatisfactory. Targeted therapy with monoclonal antibodies directed against B cells and against cytokines has met … Read more
- B cell-targeted therapies in autoimmune skin disease: current advances and challengesby inmunoadminCurr Opin Immunol. 2025 Aug 14;96:102643. doi: 10.1016/j.coi.2025.102643. Online ahead of print. ABSTRACT Autoimmune skin diseases (AISDs) constitute a group of skin disorders driven by B cell-mediated autoimmunity or dysregulation of other immune cell populations. AISD can be further divided into systemic autoimmune disease with skin involvement, such as systemic lupus erythematosus (SLE), and skin-specific … Read more
- Implication of epigenetic factors in development and recurrence of psoriasisby inmunoadminCurr Opin Immunol. 2025 Aug 14;96:102636. doi: 10.1016/j.coi.2025.102636. Online ahead of print. ABSTRACT Psoriasis is a chronic autoimmune skin disease characterized by abnormal proliferation and differentiation of keratinocytes, with a complex pathogenesis often linked to environmental and genetic factors. Although many treatments are available, the disease still exhibits a high recurrence rate. Epigenetic regulation appears … Read more
- Can juvenile idiopathic arthritis be cured?by inmunoadminCurr Opin Immunol. 2025 Aug 11;96:102632. doi: 10.1016/j.coi.2025.102632. Online ahead of print. ABSTRACT Juvenile idiopathic arthritis (JIA) is the most common rheumatological disorder affecting children. It is characterized by chronic synovial inflammation that may lead to permanent joint damage and disability. JIA is an umbrella term for a heterogenous group of subtypes based on specific … Read more
- Can sarcoidosis be cured?by inmunoadminCurr Opin Immunol. 2025 Aug 9;96:102637. doi: 10.1016/j.coi.2025.102637. Online ahead of print. ABSTRACT Sarcoidosis is a systemic granulomatous disease of unknown cause that affects the lungs almost invariably. The clinical course and outcomes of pulmonary sarcoidosis are highly variable, ranging from mild and self-limiting to organ-threatening or life-threatening disease. Often, sarcoidosis remits permanently (spontaneously or … Read more
- Eliciting or silencing complement activation: strategies for optimizing monoclonal antibodies functionsby inmunoadminCurr Opin Immunol. 2025 Aug 7;96:102638. doi: 10.1016/j.coi.2025.102638. Online ahead of print. ABSTRACT Tuning complement activity is essential to maximize therapeutic efficacy while minimizing off-target effects in monoclonal antibody (mAb) design. Complement-enhancing strategies are primarily applied to mAbs targeting pathogens, infected cells, tumors, or immunosuppressive cells within the tumor microenvironment. In contrast, complement-silencing strategies are … Read more
- Intracellular complement in monocytes and macrophages: emerging rolesby inmunoadminCurr Opin Immunol. 2025 Aug 6;96:102629. doi: 10.1016/j.coi.2025.102629. Online ahead of print. ABSTRACT Macrophages and the complement system are fundamental components of innate immunity, emerging early in evolutionary history. The well-established functions of complement in relation to macrophages contribute to both innate and adaptive immunity and are mediated by extracellular components acting systemically or locally … Read more
- Complement in antiphospholipid syndrome, time to target?by inmunoadminCurr Opin Immunol. 2025 Aug 6;96:102628. doi: 10.1016/j.coi.2025.102628. Online ahead of print. ABSTRACT Antiphospholipid syndrome (APS) is an acquired autoimmune thrombophilia. Complement system, which shares common actors with the coagulation cascade, is nowadays well established to be implicated in APS pathophysiology by different mechanisms. In APS, complement activation assessment is not included in the routine … Read more
- Neuropsychiatric lupus: a myriad of symptoms requires a myriad of modelsby inmunoadminCurr Opin Immunol. 2025 Aug 6;96:102631. doi: 10.1016/j.coi.2025.102631. Online ahead of print. ABSTRACT Neuropsychiatric lupus (NPSLE) is believed to manifest in 30-40% of SLE patients, with symptoms spanning from fatigue and anxiety to depression, cognitive impairment, and psychosis. Over the past decades, it has become clear that most animal models of SLE also present with … Read more
- Epigenetic regulation of inflammation dynamics during wound healing: a subtle yet profound shift in histone modificationsby inmunoadminCurr Opin Immunol. 2025 Aug 5;96:102635. doi: 10.1016/j.coi.2025.102635. Online ahead of print. ABSTRACT Wound healing represents a dynamic process centered on the temporally coordinated inflammatory, proliferative, and remodeling phases. The inflammatory response exhibits a double-edged role: a moderate response is essential for normal healing, but excessive or persistent response impedes repair processes. In normal wound … Read more